Happy HIT - Der Histaminintoleranz & Mastzellen Podcast
by Nora Hodeige & Jacqueline Hallmann
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇩🇪DE · Alternative Health#6730K to 100K
- 🇬🇷GR · Alternative Health#733K to 10K
- 🇦🇹AT · Alternative Health#172500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
17K to 57K🎙 Weekly cadence·153 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
34K to 113K🇩🇪88%🇬🇷9%🇦🇹3% - Active Followers
Loyal subscribers who consistently listen
10K to 34K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
#153 [Interview] - Histaminintoleranz nach Corona: „Ich dachte, das Essen ist das Problem. Heute weiß ich, dass es etwas ganz anderes war.“ - Melanie's LMO-Erfahrung
Jul 7, 2026
1h 16m 18s
#152 [Talk] Die letzte aktive Folge: Eure Fragen zu HIT & MCAS – und was jetzt kommt
Mar 4, 2026
1h 28m 13s
#151 [Interview] 5 Lebensmittel, chronisch erschöpft & völlig verloren – Irinas Geschichte raus aus der Histamin-Hölle
Feb 11, 2026
43m 56s
#150 [Interview] Von 11 Lebensmitteln zurück ins Leben – Katja erzählt ihre Geschichte mit HIT & MCAS
Jan 28, 2026
1h 09m 11s
#149 [Info] „Ich hab nicht nur Histamin – hilft das auch bei Fructose, Allergien & Co.?“
Jan 14, 2026
19m 18s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/7/26 | HistaminintoleranzCorona+3 | Melanie | — | — | HistaminintoleranzCorona+5 | — | 1h 16m 18s | ||
| 3/4/26 | HistaminintoleranzMastzellen+5 | — | Happy HIT PodcastRebirth | Deutschland | HITMCAS+8 | — | 1h 28m 13s | ||
| 2/11/26 | HistaminintoleranzErschöpfung+3 | Irina | Happy HIT Podcast | — | HistaminintoleranzErschöpfung+3 | — | 43m 56s | ||
| 1/28/26 | HistaminintoleranzMastzellen+3 | Katja | — | — | HistaminintoleranzMastzellen+3 | — | 1h 09m 11s | ||
| 1/14/26 | HistaminintoleranzFructoseunverträglichkeit+4 | — | Happy HIT PodcastHistaminintoleranz+6 | — | HistaminintoleranzFructose+5 | — | 19m 18s | ||
| 12/31/25 | JahresrückblickNervensystem+3 | — | — | — | JahresrückblickNervensystem+3 | — | 19m 17s | ||
| 12/17/25 | HistaminintoleranzWeihnachtsmenü+4 | — | — | — | HistaminintoleranzWeihnachten+3 | — | 23m 59s | ||
| 12/3/25 | MeditationJournaling+3 | — | — | — | MeditationJournaling+3 | — | 34m 23s | ||
| 11/19/25 | Leaky GutHistaminintoleranz+4 | — | Happy HIT Podcast | DarmLeaky Gut+2 | Leaky GutHistamin+4 | — | 27m 43s | ||
| 11/5/25 | PsychosomatikMind-Body-Einflüsse+5 | — | Emotional Freedom Techniques | — | PsychosomatikMind-Body+5 | — | 35m 12s |
Showing 10 of 10
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Happy HIT - Der Histaminintoleranz & Mastzellen Podcast
Peaked at #67 in Germany, currently #67 in Germany.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Germany | — | #67 | #67 | — |
| GR | — | #73 | #73 | — |
| AT | — | #172 | #172 | — |
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.